Loading...
Loading...
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc.. Spoken Alpha tracks SPTX's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks SPTX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SPTX.
curl https://api.spokenalpha.com/v1/companies/SPTX| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.65 | $2.06 | -20.1% | -2.5% | -0.7% |
| Q4 FY2026 | $1.57 | $1.86 | -15.6% | +0.2% | +1.2% |
| Q3 FY2026 | $1.75 | $1.94 | -9.8% | +4.3% | +7.0% |
| Q2 FY2026 | $1.54 | $1.92 | -19.9% | +3.3% | +1.9% |
| Q1 FY2025 | $1.90 | $2.13 | -10.6% | -3.9% | -2.7% |
| Q4 FY2025 | $1.63 | $2.02 | -19.4% | -1.0% | +0.7% |
| Q3 FY2025 | $1.59 | $2.01 | -21.0% | +0.8% | -1.6% |
| Q2 FY2025 | $1.99 | $2.18 | -8.8% | -4.3% | -5.7% |
| Q1 FY2024 | $1.78 | $2.05 | -13.3% | -5.0% | -5.7% |
| Q4 FY2024 | $1.94 | $2.24 | -13.3% | +3.9% | +6.6% |